Related Experiment Video
Updated: Jan 11, 2026

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
Pathologic analysis of melanocytic neoplasms
Jane L Messina1,2, Julie Gibbs3
1Departments of Anatomic Pathology and Cutaneous Oncology, H. Lee Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, Florida, USA. jane.messina@moffitt.org.
Abstract:
Recent advances in techniques for pathologic evaluation of melanocytic neoplasms, updates in staging, and novel treatment and prognostic assays have brought pathologists to the forefront of the care of the melanoma patient. Specimen procurement, handling, and evaluation are all key to the production of a pathology report that guides the clinician to the proper treatment of the patient. Recent, relevant changes in the pathologic analysis of melanocytic neoplasms, highlighting the AJCC 8th edition guidelines, and pathologic changes related to therapy are discussed herein. Also included is a discussion of molecular assays used to aid in diagnosis of challenging lesions, predict clinical outcome, and predict response to targeted therapy.

